ALLISON WILBANKS: Open Payments
NPI 1366720179 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,359 in 103 payments from 18 companies in 2025. Trend: 2023 $2,702 · 2024 $2,264 · 2025 $2,359
Food & beverage: $2,359
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $444 |
| UCB, Inc. | 13 | $296 |
| PFIZER INC. | 11 | $295 |
| Arcutis Biotherapeutics, Inc. | 8 | $232 |
| Lilly USA, LLC | 8 | $164 |
| GENZYME CORPORATION | 7 | $156 |
| Novartis Pharmaceuticals Corporation | 4 | $114 |
| Incyte Corporation | 5 | $102 |
| Janssen Biotech, Inc. | 4 | $84 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $78 |
Products named: Bimzelx, CIBINQO, RINVOQ, Zoryve, SKYRIZI, TALTZ, DUPIXENT, OPZELURA.
Industry payments across TX — which companies pay providers there.
